IRIS  Catalogo Istituzionale della Ricerca dell'Università degli Studi del Molise

PERROTTA, Fabio Massimo
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.151
NA - Nord America 2.146
AS - Asia 353
AF - Africa 276
SA - Sud America 22
OC - Oceania 11
Continente sconosciuto - Info sul continente non disponibili 8
Totale 4.967
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.132
IE - Irlanda 770
CI - Costa d'Avorio 270
IT - Italia 212
AT - Austria 192
FI - Finlandia 174
RU - Federazione Russa 167
UA - Ucraina 160
SG - Singapore 146
DE - Germania 134
CN - Cina 132
FR - Francia 85
SE - Svezia 79
GB - Regno Unito 63
PL - Polonia 53
IN - India 23
BE - Belgio 16
AU - Australia 11
CA - Canada 11
BR - Brasile 10
NL - Olanda 10
EU - Europa 8
TR - Turchia 7
CL - Cile 6
IR - Iran 6
CH - Svizzera 4
CO - Colombia 4
EG - Egitto 4
ES - Italia 4
HK - Hong Kong 4
TH - Thailandia 4
BG - Bulgaria 3
CZ - Repubblica Ceca 3
DK - Danimarca 3
IL - Israele 3
JP - Giappone 3
LT - Lituania 3
LV - Lettonia 3
MY - Malesia 3
CY - Cipro 2
GR - Grecia 2
ID - Indonesia 2
KG - Kirghizistan 2
KR - Corea 2
LK - Sri Lanka 2
NO - Norvegia 2
PA - Panama 2
PT - Portogallo 2
RO - Romania 2
SA - Arabia Saudita 2
UZ - Uzbekistan 2
VN - Vietnam 2
AR - Argentina 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BY - Bielorussia 1
IM - Isola di Man 1
KZ - Kazakistan 1
LA - Repubblica Popolare Democratica del Laos 1
MA - Marocco 1
MK - Macedonia 1
MX - Messico 1
PE - Perù 1
PH - Filippine 1
RS - Serbia 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
TW - Taiwan 1
Totale 4.967
Salva come PNG Salva come JPEG
Città #
Dublin 770
Chandler 439
Jacksonville 377
Abidjan 270
Vienna 191
Helsinki 150
Ann Arbor 117
Wilmington 106
Singapore 95
San Mateo 78
Princeton 61
Warsaw 53
Houston 52
Rome 52
Woodbridge 50
Boardman 43
Dearborn 42
Los Angeles 35
New York 31
Ashburn 29
Beijing 28
Dallas 24
Molise 20
Redwood City 20
Brussels 16
Jinan 14
Milan 14
Moscow 12
Mountain View 11
Nanjing 9
London 8
Manchester 8
Borås 7
Esslingen am Neckar 7
Leawood 7
Rochester 7
Shenyang 7
Ardabil 6
Augusta 6
Frankfurt am Main 6
Haikou 6
Ningbo 6
Rockville 6
Changsha 5
Chennai 5
Falls Church 5
Guangzhou 5
Newark 5
Seattle 5
Taiyuan 5
Toronto 5
Zhengzhou 5
Amsterdam 4
Falkenstein 4
Fleet 4
Hefei 4
Paola 4
Shanghai 4
Tianjin 4
Ariccia 3
Bangkok 3
Chicago 3
Hong Kong 3
Ilmenau 3
Lappeenranta 3
Monmouth Junction 3
Norwalk 3
Ottawa 3
Palermo 3
Riga 3
Simi Valley 3
Sofia 3
Taizhou 3
Tokyo 3
Auburn Hills 2
Avignon 2
Bari 2
Bishkek 2
Bologna 2
Cagliari 2
Cairo 2
Campi Bisenzio 2
Cernusco sul Naviglio 2
Chiaravalle Centrale 2
Colombo 2
Eden Prairie 2
Fairfield 2
Florence 2
Forlì 2
Impruneta 2
Jaipur 2
Johns Island 2
João Pessoa 2
Kunming 2
Lanzhou 2
Letchworth Garden City 2
Naples 2
Newcastle-under-Lyme 2
Nicosia 2
Novokuznetsk 2
Totale 3.466
Salva come PNG Salva come JPEG
Nome #
Spondiloartriti assiali: dalla patogenesi della neoformazione ossea alla valutazione di possibili biomarcatori di attività di malattia e remissione clinica 237
An ultrasonographic study of enthesis in early psoriatic arthritis patients naive to traditional and biologic DMARDs treatment 125
Analysis of potential determinants for a treat-to-target strategy in psoriatic arthritis patients from a real-world setting 112
Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study. 99
Validity, responsiveness and feasibility of an Italian version of the Canadian Occupational Performance Measure for patients with ankylosing spondylitis 99
Assessment of response to treatment, remission, and minimal disease activity in axial psoriatic arthritis treated with tumor necrosis factor inhibitors 99
Sustained Very Low Disease Activity and Remission in Psoriatic Arthritis Patients 98
Incidence of rheumatoid arthritis, psoriatic arthritis and polymyalgia rheumatica in an inland area of central Italy: results of the CAMPO-RHE study 94
Beyond TNF Inhibitors: New Pathways and Emerging Treatments for Psoriatic Arthritis 90
Assessment of semaphorin 3A and its role in bone remodelling in a group of ankylosing spondylitis patients 90
Elderly psoriatic arthritis patients on TNF-α blockers: results of an Italian multicenter study on minimal disease activity and drug discontinuation rate 89
Chronic periaortitis with retroperitoneal fibrosis successfully treated with first line tocilizumab monotherapy: a case report 89
Residual disease activity in rheumatoid arthritis patients treated with subcutaneous biologic drugs that achieved remission or low disease activity: a longitudinal observational study 88
Comparison of composite indices tailored for psoriatic arthritis treated with csDMARD and bDMARD: A cross-sectional analysis of a longitudinal cohort 86
Unmet Needs in Axial Spondyloarthritis 86
Secukinumab for ankylosing spondylitis and psoriatic arthritis 84
Assessment of subclinical atherosclerosis in ankylosing spondylitis: Correlations with disease activity indices 84
An Assessment of Hand Erosive Osteoarthritis: Correlation of Radiographic Severity with Clinical, Functional and Laboratory Findings 82
Defining low disease activity states in psoriatic arthritis using novel composite disease instruments 81
Mesenchimal stem cells: A possible role in the pathogenesis and treatment of spondyloarthritis 81
From clinical remission to residual disease activity in spondyloarthritis and its potential treatment implications 81
The role of IL-17 in the treatment of psoriatic arthritis 80
Validation of the Italian version of proposed GRAPPA flare questionnaire for patients with psoriatic arthritis 80
An overview of low disease activity and remission in psoriatic arthritis. 79
Minimal Disease Activity and Remission in Psoriatic Arthritis Patients Treated with Anti-TNF-α Drugs 77
Predictors of loss of remission and disease flares in patients with axial spondyloarthritis receiving antitumor necrosis factor treatment: A retrospective study 77
Beyond the joint: Subclinical atherosclerosis in rheumatoid arthritis 76
Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs 75
Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study. 75
Assessment of bone morphogenic protein 2 and interleukine-17A in patients with axial spondyloarthritis and their potential role in the new bone formation: a cross-sectional study 75
Subcutaneous anti-TNF alfa induced sustained minimal disease activity and remission in psoriatic arthritis patients: a retrospective study 72
Rapid effectiveness of certolizumab pegol in non-radiographic axial spondyloarthritis. 71
Multimorbidity and comorbidity in psoriatic arthritis–a perspective 70
Patient's global assessment as an outcome measure for psoriatic arthritis in clinical practice: A surrogate for measuring low disease activity? 69
Psoriatic arthritis: is it time to treat-to-target or target to treat? 66
The sex influence on response to tumor necrosis factor-α inhibitors and remission in axial spondyloarthritis 66
Role of comorbidities in spondyloarthritis including psoriatic arthritis 66
Assessment of the Patient Acceptable Symptom State (PASS) in psoriatic arthritis: Association with disease activity and quality of life indices 66
New approved drugs for psoriatic arthritis. 64
Cardiovascular Risk Prediction in Ankylosing Spondylitis: From Traditional Scores to Machine Learning Assessment 64
Effectiveness of adalimumab for the treatment of psoriatic arthritis: An Italian real-life retrospective study 62
Impact of Comorbidities on Disease Activity, Patient Global Assessment, and Function in Psoriatic Arthritis: A Cross-Sectional Study 59
Clinical and ultrasonography assessment of peripheral enthesitis in ankylosing spondylitis 57
Case report of polymyalgia rheumatica in a male patient with three different neoplasms treated with pembrolizumab 57
Psoriatic arthritis, psoriatic disease, or psoriatic syndrome? 56
Serum Sclerostin as a Possible Biomarker in Ankylosing Spondylitis: A Case-Control Study 55
Ultrasonographic and Clinical Assessment of Peripheral Enthesitis in Patients with Psoriatic Arthritis, Psoriasis, and Fibromyalgia Syndrome: The ULISSE Study 55
Dr. Lubrano, et al reply 55
Assessment of widespread and extra-articular pain in psoriatic arthritis: a case-control study 55
Impact of physical activity on disability risk in elderly patients hospitalized for mild acute diverticulitis and diverticular bleeding undergone conservative management 54
To move or not to move: The paradoxical effect of physical exercise in axial spondyloarthritis 54
Occult axial involvement in patients with psoriatic arthritis mutilans: a case report 53
Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study 51
TNF-alpha inhibitors for the six treatment targets of psoriatic arthritis 49
New Insights in Physical Therapy and Rehabilitation in Axial Spondyloarthritis: A Review 48
Clinical and imaging assessment of peripheral enthesitis in Ankylosing Spondylitis 47
Residual disease activity and associated factors in Psoriatic Arthritis 46
Power Doppler ultrasonographic evaluation of enthesitis in psoriatic arthritis. A multi-center study 44
Remission, low disease activity and improvement of pain and function in psoriatic arthritis patients treated with IL-12/23 and IL-17 inhibitors. A multicenter prospective study 40
Rheumatology Care in the Face of COVID-19 40
SARS-CoV-2 IgM False-Positivity in a Psoriatic Arthritis Patient Seropositive for Rheumatoid Factor and ACPA: An Interference of Immune Response? 33
Dactylitis and Early Onset Psoriasis in Psoriatic Arthritis: Are they Markers of Disease Severity? A Clinical Study 32
Clinical Characteristics of Potential "Difficult-to-treat" Patients with Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 32
MRI Assessment of Extra-axial Findings at Pelvic Sites in a Group of Axial-SpA Patients 32
Psoriatic Arthritis in Males and Females: Differences and Similarities 29
The "Climb" Towards Minimal Disease Activity in Psoriatic Arthritis 28
The Conundrum of Psoriatic Arthritis: a Pathogenetic and Clinical Pattern at the Midpoint of Autoinflammation and Autoimmunity 28
Constrictive Pericarditis With Massive Calcification in Systemic Sclerosis Treated With Pericardiectomy: A Case Report 28
Therapeutic Targets for Ankylosing Spondylitis - Recent Insights and Future Prospects 24
New Insights in Physical Therapy and Rehabilitation in Psoriatic Arthritis: A Review 24
Sequencing of Biologic and Target Synthetic Disease-Modifying Anti-Rheumatic Drugs in Psoriatic Arthritis: Are we Ready to Redefine the Treatment Strategy? A Perspective 24
Cardiovascular comorbidities in psoriatic arthritis: epidemiology and risk factors in two different European populations 23
Inflammatory bowel disease manifestations in spondyloarthritis: considerations for the clinician 22
Ultrasonographic Evaluation of Entheseal Fibrocartilage in Patients with Psoriatic Arthritis, Athletes and Healthy Controls: A Comparison Study 21
Livelli aumentati di IL19 nel liquido sinoviale di pazienti con artrite psoriasica 21
Valutazione ecografica del tendine di Achille e dell'entesi rotulea nei giocatori di calcio e basket: potrebbe essere utile per prevedere lo sviluppo di lesioni muscolari e tendinee? 20
Extra-Articular Manifestations and Comorbidities in Psoriatic Disease: A Journey Into the Immunologic Crosstalk 20
Valutazione dei fattori predittivi per il raggiungimento della remissione parziale (RP) secondo i criteri ASAS nei pazienti con Spondilite Anchilosante (SA) trattati con farmaci antagonisti del TNF 20
Patient reported outcomes in early vs late diagnosis of psoriatic arthritis|Resultados informados por los pacientes en el diagnóstico precoz respecto a los pacientes con diagnóstico tardío en la artritis psoriásica 17
Use of Ultrasonography to Discriminate Psoriatic Arthritis from Fibromyalgia: A Post-Hoc Analysis of the ULISSE Study 16
Assessment of Patient-Physician Interactions in Psoriatic Arthritis: National Results of the ASSIST Study 15
Clinical Characteristics of "Severe" Peripheral Psoriatic Arthritis: A Retrospective Analysis of a Longitudinal Cohort 14
VALUTAZIONE DELLA REMISSIONE CLINICA SECONDO I CRITERI ASAS NEI PAZIENTI CON SPONDILOARTRITE ASSIALE TRATTATI CON FARMACI BIOLOGICI ANTAGONISTI DEL TNF ALPHA: STUDIO RETROSPETTIVO MULTICENTRICO 13
Identification of the Minimal Disease Activity Domains Achieved Based on Different Treatments in Psoriatic Arthritis 12
Triple jump for the optimal management of psoriatic arthritis: Diet, sleep and exercise - A review 12
Elevated levels of IL-19 in the joints of patients with psoriatic arthritis 12
Two sides of management recommendations for psoriatic arthritis 10
The assessment of the drug retention rate of secukinumab in patients with psoriatic arthritis in a real-life multicentre cohort 10
Difficult-to-treat concept in Psoriatic Arthritis: analysis of two potential definitions in a large group of patients. A cross-sectional study 10
Sensitivity and Specificity of Composite Indices of Remission in Male and Female Patients With Psoriatic Arthritis: A Multicenter Cross-Sectional Study of Longitudinal Cohorts 9
Difficult to Treat and Refractory to Treatment in Psoriatic Arthritis 9
Sex-related differences in psoriatic arthritis 8
Psoriatic Arthritis Acceptable Symptoms State: Does Sex Make a Difference? 5
Male Fertility in Spondyloarthritis: from Clinical Issues to Cytokines Milieu. A Narrative Review 4
Totale 5.116
Salva come PNG Salva come JPEG
Categoria #
all - tutte 27.984
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 27.984
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020401 0 0 0 0 50 25 116 34 64 44 12 56
2020/2021582 20 57 4 83 103 28 76 12 76 15 99 9
2021/2022359 15 76 16 17 17 7 10 38 49 71 14 29
2022/20231.805 218 74 34 151 68 126 15 86 895 67 39 32
2023/2024473 132 68 34 19 23 51 2 33 17 23 19 52
2024/2025767 319 69 193 21 165 0 0 0 0 0 0 0
Totale 5.116